Trypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders.
BACKGROUND:The immune mechanisms underlying experimental non-alcoholic steatohepatitis (NASH), and more interestingly, the effect of T. cruzi chronic infection on the pathogenesis of this metabolic disorder are not completely understood. METHODOLOGY/PRINCIPAL FINDINGS:We evaluated immunological para...
Saved in:
Main Authors: | Luisina I Onofrio (Author), Alfredo R Arocena (Author), Augusto F Paroli (Author), María E Cabalén (Author), Marta C Andrada (Author), Roxana C Cano (Author), Susana Gea (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Importance of TLR2 on hepatic immune and non-immune cells to attenuate the strong inflammatory liver response during Trypanosoma cruzi acute infection.
by: Eugenio Antonio Carrera-Silva, et al.
Published: (2010) -
Correction: Importance of TLR2 on Hepatic Immune and Non-Immune Cells to Attenuate the Strong Inflammatory Liver Response During Trypanosoma cruzi Acute Infection.
by: Eugenio Antonio Carrera-Silva, et al.
Published: (2023) -
Nanoemulsions of sulfonamide carbonic anhydrase inhibitors strongly inhibit the growth of Trypanosoma cruzi
by: Alane Beatriz Vermelho, et al.
Published: (2018) -
Biology of Trypanosoma cruzi: An update Biología del Trypanosoma cruzi: Actualización
by: André Vianna Martins, et al.
Published: (2012) -
Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi.
by: Joseph D Planer, et al.
Published: (2014)